Company ProfilePremium

GHCL Limited

Company Profile Analysis

Ticker: GHCL.NS

ESOMAR 23 Corporate BadgeISO Certifications Badge
GHCL Limited - Company showcase

Year Founded & Workforce

1983

744 Employees

GHCL Limited logo

GHCL Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

GHCL Limited Overview

AttributeDetailSource
Legal nameGHCL Limited[NSE-GOV]
Former nameGujarat Heavy Chemicals Limited (the market still frequently uses this name)Angel One (Jan 2025); PitchBook
Date of incorporation14 October 1983 (some databases cite 21 July 1983; MCA/BRSR show 14-10-1983)[BRSR FY22]; MCA-derived registries
Corporate Identity Number (CIN)L24100GJ1983PLC006513Exchange filings
Incorporation jurisdictionGujarat, India (Registrar of Companies, Ahmedabad)MCA registry
Registered office"GHCL House", Opp. Punjabi Hall, Near Navrangpura Bus Stand, Navrangpura, Ahmedabad, Gujarat – 380009, IndiaExchange filings
Corporate officeGHCL House, B-38, Institutional Area, Sector-1, Noida, Uttar Pradesh – 201301, IndiaExchange filings
Stock exchanges / tickersNational Stock Exchange of India: GHCL; BSE Limited: 500171Exchange filings
ISININE539A01019Exchange data
LEI335800L2UYNOUH82F930financialfilings.com
CUSIPNot applicable (no US listing)—
Index membershipBSE Commodities, Nifty Microcap 250, Nifty Total Market, BSE 1000[SCR]
Fiscal year end31 March[NSE-GOV]
Face value per share₹10[SCR]
Registrar & transfer agentMUFG Intime India Pvt Ltd (formerly Link Intime), MumbaiJhaveri Trade company profile
Credit ratingCARE AA-; Stable (long-term) / CARE A1+ (short-term), reaffirmed 10 August 2026[CARE26]
Statutory auditorn/d in sources reviewed for FY26 (the 5 May 2026 board agenda included auditor appointments; consult FY26 Annual Report)[Q4FY26] board notice
Internal auditorsSeparate firms appointed for Soda Ash and Consumer Products divisions (firm names partially reported; R J Goel & Co. among appointees)ScanX summary of 5 May 2026 board outcome
Websitewww.ghcl.co.in—
Only subsidiaryDan River Properties LLC (USA), 100%[CARE26]; [BRSR FY24]
Promoter groupDalmia family (Anurag Dalmia, Neelabh Dalmia, Anurag Dalmia HUF, Dalmia Finance Ltd, Dalmia Housing Finance Ltd, Ram Krishna Dalmia Foundation, among others)Promoter declaration, April 2026
MetricFY22FY24FY26
Total permanent employees (BRSR, standalone, excl. workers)744497—

Employee counts are inconsistently reported across sources, reflecting differing scopes (permanent employees vs. permanent workers vs. contract labour) and the 2023 demerger of the labour-intensive textile business.

Notes: FY22 includes the then-integrated yarn business [BRSR FY22]; FY24 is post-demerger [BRSR FY24]. Third-party databases give materially different totals — PitchBook cites 3,439 and EMIS cites 1,037 (2026); an MCA-derived registry cites ~1,298. None of these is company-verified.

Market capitalisation (current)

MetricValueDate / Source
Share price₹463Latest Screener snapshot, early October 2026 [SCR]
Market capitalisation₹4,257 Cr[SCR]
Shares outstanding (derived)~9.19 crore sharesMarket cap ÷ price; consistent with equity capital of ₹92 Cr at ₹10 FV [SCR FY26]
52-week high / low₹668 / ₹419[SCR]
Cross-check₹4,087 Cr at ~₹442 on 28 August 2026share.market

GHCL Limited is India's second-largest producer of soda ash (anhydrous sodium carbonate), operating a single, highly utilised 1.2 million-tonne-per-annum synthetic (Solvay-process) complex at Sutrapada on the Saurashtra coast of Gujarat, with roughly a 26% share of the domestic market. Following the 2023 demerger of its yarn business into GHCL Textiles, it is effectively a pure-play inorganic chemicals company: soda ash accounts for about 98% of standalone revenue, supplemented by refined sodium bicarbonate, industrial salt and a small consumer-products division. Its strategic edge rests on partial captive sourcing of salt, limestone and lignite, best-in-class plant utilisation (~96% in FY26) and an effectively debt-free balance sheet holding over ₹1,100 crore of cash and liquid investments. The company is now diversifying into bromine and vacuum salt, and is preparing a phased 1.1 million-tonne greenfield soda ash plant in Kutch to roughly double capacity by around 2030.


What the company does

GHCL manufactures and sells commodity inorganic chemicals centred on soda ash. Soda ash is a bulk industrial alkali used predominantly in flat and container glass, detergents and soaps, sodium silicate and other chemicals, and — increasingly — in solar glass, lithium carbonate processing (battery supply chains) and flue-gas desulphurisation. GHCL produces both light and dense soda ash grades, as well as refined sodium bicarbonate (RBC), and operates captive salt works that feed the soda ash process. A small consumer products division (edible salt and related packaged goods) remains within the company. [SCR company description; CARE26; Q4FY26 board outcome references to "Soda Ash and Consumer Product divisions"]

The company's own description in recent investor presentations frames it as a "leading soda ash player focused on India's growth market" and emphasises differentiators such as best-in-class capacity utilisation, productivity, operational innovation, customer servicing, and roughly three decades of management continuity. [Q1FY27-PR]

Business model and revenue model

Product vs. service mix: Essentially 100% product revenue. There is no material service, subscription or licensing revenue. Soda ash is ~98.30% of standalone revenue. [SCR, citing company disclosures]

Pricing mechanism: Domestic soda ash prices are not administered; they broadly track the landed price of imported soda ash because India has had neither a structural import duty nor quotas in recent years. Realisations therefore move with global prices (driven by Chinese, Turkish, US and Russian supply), freight rates and the INR/USD exchange rate. [CARE26] The government imposed a Minimum Import Price (MIP) of ₹20,108/tonne (CIF) from 30 December 2024, subsequently extended, which acts as a partial floor. [DGFT Notification 46/2024-25; Outlook Business]

Cost structure: Key variable inputs are salt (partly captive), limestone (partly captive and partly imported), coal, coke, lignite (partly captive) and power/steam; freight is material on both inputs and outputs. [CARE26] Fixed costs are predominantly rupee-denominated, giving operating leverage to any rise in import-parity prices.

Contracting: GHCL supplies leading domestic glass and detergent manufacturers on long-standing relationships; contract tenor and pricing formulas are n/d. [CARE26]

Value-chain position

GHCL sits in the upstream-to-midstream position of the alkali chain: it converts mined/harvested raw materials (salt brine, limestone, coke/lignite for kiln and boiler fuel, ammonia as a process recycle agent in Solvay) into a basic chemical intermediate that is sold business-to-business to downstream manufacturers. Its backward integration (captive salt pans, limestone and lignite leases) is partial; forward integration is limited to sodium bicarbonate and, prospectively, bromine (a co-product extractable from salt bitterns) and vacuum salt.

Customer types and end-markets

End-marketRole of soda ashRelevance to GHCL
Detergents & soapsBuilder/alkali in powders and cakesTraditional anchor demand; long-standing FMCG relationships [CARE26]
Flat & container glassFlux in glass batch (~20% of batch)Anchor demand; container glass tied to food/beverage/pharma packaging
Solar glassFlux for low-iron patterned glassFastest-growing new vector; management expects solar glass to consume ~8–9% of Indian soda ash demand "soon" [Q1FY27 call summary, Arthneeti]
Sodium silicate & chemicalsFeedstockSteady
Lithium carbonate / batteriesReagent in lithium processingEmerging; cited by management as a "strong new vector" [Q1FY27-PR]
Flue-gas treatmentSorbentCited by CARE as a growth driver through 2031 [CARE26]
Sodium bicarbonate customersFood (baking), pharma, animal feed, fire extinguishersServed by RBC capacity of 1.2 lakh MTPA [CARE26]

Independent characterisation

GHCL is best characterised as a low-cost, single-site commodity producer in an oligopolistic but import-exposed national market. Its economics are those of a price-taker whose margin is determined by (i) the spread between import-parity soda ash prices and its delivered input costs, and (ii) its ability to run the plant at near-nameplate capacity. Since FY24 the investment case has shifted from a "chemicals + textiles conglomerate" to a "focused soda ash compounder with optionality": the textile demerger removed a lower-return, cyclical business; cash has accumulated (₹1,113 Cr of cash and liquid investments at FY26 end per [CARE26]); and the forward narrative hinges on the timing and execution of the Kutch greenfield project and the small but high-margin bromine/vacuum salt diversification. The near-term P&L remains hostage to Chinese overcapacity, the trade-remedy regime and West Asia-related freight dislocation.

Strategy

Stated strategic themes

From recent investor presentations and management commentary [Q1FY27-PR; Q4FY26; Q3FY26]:

  1. Focus on India's soda ash growth market — capture incremental domestic demand of an estimated 2.5–3.0 lakh tonnes per year (market growing 5–6% p.a.).

  2. Cost leadership and operational excellence — best-in-class utilisation, productivity and "operational innovation"; "focus on what is within our control".

  3. Capacity doubling via greenfield — from 12 lakh to ~23 lakh MTPA by ~2030 via the Kutch project, raising market share ambition toward ~30%.

  4. Adjacent, high-margin diversification — bromine and vacuum salt leveraging salt assets.

  5. Disciplined capital allocation — debt-free balance sheet, internal accrual funding, regular dividends and opportunistic buybacks.

  6. Sustainability — framework built on climate action, stakeholder centricity and a "zero-harm" safety initiative; EV truck logistics electrification.

  7. Trade-policy advocacy — pressing for anti-dumping duties to address import surges.

Initiative register (last 24 months)

InitiativeTypeAnnounced / statusInvestment / targetSource
Kutch greenfield soda ash (Bada, Mandvi)Capacity expansionBoard approval May 2024; EC received; NGT appeals dismissed 21 Aug 2026; land acquisition delays; "slow progress"; no firm zero date; commissioning by 2030 at earliest11 lakh MTPA in two phases; Phase I ~₹4,000 Cr (incl. common infrastructure), Phase II ~₹1,000 Cr; term debt ~₹2,000–2,500 Cr; FY27 spend ~₹100 Cr[CARE26]; [BSE-2024]; Sahi; Arthneeti
Bromine project (Phase 1)DiversificationIn advanced commissioning; COD scheduled Q2 FY27~₹115–120 Cr capex (FY24 guidance)[Q1FY27-PR]; Arthneeti FY24 call summary
Bromine Phase 2DiversificationPlanned on newly acquired government land; 3–4 years post land formalities10,000–12,000 t; capex n/dArthneeti Q4 FY26 summary
Vacuum salt plantDiversificationIn advanced commissioning; COD scheduled Q2 FY27~₹150–170 Cr capex (FY24 guidance)[Q1FY27-PR]
Zara Zumara salt worksBackward integration6,449 ha, 30-year lease (allotted ~2024)n/d (roic.ai cites ~₹350 Cr salt field)Q1 FY25 call
Sodium bicarbonate expansionCapacityCompleted FY25—Q1 FY25 call
Salt yield improvement programmeEfficiencyOngoing—Q1 FY25 call
₹300 Cr share buybackCapital returnCompleted Nov–Dec 202541,37,931 shares at ₹725[BUYBACK]
EV truck initiative / GreenLine partnershipSustainability / Scope 3Oct 2024 onwards—Q1 FY27 presentation; roic.ai
Supplier ESG programme (with AuthBridge)Responsible sourcingOngoingAll suppliers sign Supplier Code of Conduct[CARE26]; roic.ai
Renewable energyDecarbonisation6.7 MW installed at FY26 endFurther targets n/d[CARE26]
Efficiency & value-added products capexMaintenance/efficiencyFY27~₹150 Cr[CARE26]

Medium-term targets and guidance

Capacity: ~23 lakh MTPA by 2030 (from 12 lakh). [Sahi; Angel One Oct 2025]

Market share ambition: ~30% (from ~26%). [Procurement Resource summary — secondary]

New businesses: ~₹120 Cr revenue in FY27 at 40–45% EBITDA margin. [Q4FY26 call summary — secondary]

Capex: Regular capex historically guided at ~₹250 Cr p.a. excluding greenfield; FY27 ~₹250 Cr (₹150 Cr efficiency/value-added + ₹100 Cr greenfield) per CARE. [CARE26; FY24 call summary]

No formal revenue/EBITDA guidance: is issued by management. CARE's independent base case: total operating income CAGR of ~4–5% and PBILDT of ~₹750–850 Cr p.a. in the medium term. [CARE26]

Products & Services

All products sit within the Inorganic Chemicals segment. Specifications are summarised from public descriptions; grade-level technical data sheets and price lists are n/d.

Guidance on the new businesses: Management guided at the Q4 FY26 call that bromine and vacuum salt would add approximately ₹120 Cr of revenue in FY27 at a 40–45% EBITDA margin. [Q4FY26 call, Arthneeti summary — secondary] At that run-rate the diversification would add roughly ₹50 Cr of EBITDA (derived), about 7% of FY26 EBITDA.

Product Portfolio

ProductDescription & key specificationsCapacity / scaleTarget customersLaunch / latest statusPricing model

Soda Ash – Light

Anhydrous sodium carbonate (Na₂CO₃), low bulk density (~0.5–0.6 t/m³ typical for light grade), produced via Solvay ammonia-soda process

Part of 12 lakh MTPA total soda ash capacity; ~96% utilisation FY26

Detergents, soaps, sodium silicate, chemicals

Since plant commissioning (late 1980s †)

Spot/contract; tracks landed import price; FY26 average realisation ₹23,709/t (all grades) [CARE26]

Soda Ash – Dense

Densified grade for glass furnaces (higher bulk density, low dusting)

Part of 12 lakh MTPA

Flat glass, container glass, solar glass

Ongoing

As above

Refined Sodium Bicarbonate (RBC)

NaHCO₃ refined from soda ash; food/pharma/feed/industrial grades

1.20 lakh MTPA installed; expansion completed in FY25

Bakery/food, pharma, animal feed, fire-fighting, leather

Expanded FY25

Contract/spot; n/d

Industrial Salt

Solar salt from captive salt works; feedstock for soda ash and merchant sale

3 lakh MTPA salt production capacity [CARE26]; Zara Zumara 6,449 ha lease adds future capacity

Captive (soda ash brine); chlor-alkali and other users

Ongoing; new Kutch salt works under development (₹350 Cr salt field planned; per roic.ai)

—

Bromine (new)

Elemental bromine recovered from salt bitterns

Phase 1 capacity n/d; management cites ambition to lift elemental bromine output "north of 18,000 tons" and a Phase-2 bromine project of 10,000–12,000 t on newly acquired government land (3–4 years post land formalities) [Q4FY26 call, Arthneeti summary — secondary]

Flame retardants, pharma, agrochemicals, oil-field chemicals, water treatment

Commercial operations scheduled Q2 FY27 [Q1FY27-PR]; confirmation of COD not yet seen as of 6 Oct 2026

Global benchmark-linked; n/d

Vacuum Salt (new)

High-purity evaporated salt (≥99.5% NaCl typical for vacuum salt)

Capacity n/d; combined bromine + vacuum salt capex ~₹300 Cr (vacuum salt ~₹150–170 Cr) [FY24 call summary]

Chlor-alkali membrane cells, food-grade salt, pharma

Commercial operations scheduled Q2 FY27 [Q1FY27-PR]

—

Consumer Products

Packaged edible salt and allied consumer goods (brand-level detail n/d in sources reviewed)

Small (<2% of revenue)

Retail/FMCG distribution

Ongoing as a separate division with its own internal auditor

MRP-based retail pricing

Financial Narrative

Basis: Consolidated, ₹ Cr, Ind AS, audited annual figures FY22–FY26 [SCR]. FY22 and FY23 include the textile (yarn) business, which was demerged effective 1 April 2023; FY24–FY26 are continuing soda ash operations only. Note that the company's press-release "net revenue" includes other income (e.g., FY25 "net revenue" ₹3,273 Cr standalone ≈ revenue from operations ₹3,183 Cr + other income ₹88 Cr consolidated).

Income statement

Gross profit: n/d (Indian P&L format does not report cost of goods sold separately in the databases reviewed). Diluted EPS: n/d separately; dilution from ESOPs is immaterial (e.g., 1.96 lakh shares allotted under ESOP in mid-2026, ~0.2% of shares). Operating income (EBIT) is shown in 6.4.

Standalone cross-check: FY26 standalone PAT ₹478.81 Cr (FY25: ₹626.23 Cr, –23.5%); standalone total revenue ₹3,143.93 Cr (FY25: ₹3,273.21 Cr, –3.95%). [Q4FY26; Torus Digital]

Margins and growth

All derived from 6.1. EBIT = EBITDA – depreciation (excludes other income). FY22 revenue growth computed against FY21 revenue of ₹2,491 Cr [SCR]; FY22 profit growth against FY21 PAT of ₹326 Cr. Revenue CAGR FY22–FY26: –5.1% (derived), distorted by the demerger; Screener reports 5-year sales CAGR of ~4% and 3-year CAGR of –12%.

Dividends per share

FY25 and FY26 DPS of ₹12 are company-declared (120% of face value). [FilingReader, Nov 2025; Angel One, May 2026] FY23 ₹17.5 per Simply Wall St headline and consistent with 15% payout on EPS of ₹119.41 (derived); FY24 ₹12 derived from 14% payout on EPS of ₹82.94 — treat as indicative. FY22 payout shown as 0% in [SCR] on a fiscal-year-of-declaration basis; FY22 DPS n/d.

Balance sheet

Sources: [SCR]; cash and liquid investments from [CARE25] (FY24, FY25) and [CARE26] (FY26). Net debt derived. CARE reports FY26 tangible net worth of ₹3,535 Cr and total debt of ₹83 Cr. Short-term vs. long-term debt split: only partially disclosed — the rated term loan outstanding was ₹54.95 Cr (maturing 30 June 2028) as of August 2026, with fund-based working capital limits largely unutilised. [CARE26] Goodwill and intangibles: n/d (not material in sources reviewed). Working capital (current assets – current liabilities): n/d.

Cash flow

Sources: [SCR]; FY26 buyback and dividends paid from [Q4FY26] (management stated it distributed ₹415 Cr to shareholders in FY26 = ₹300 Cr buyback + ₹115 Cr dividends, and repaid ₹335 Cr of borrowings including working-capital lines). Source discrepancy: CARE reports FY26 CFO of ₹719 Cr (FY25: ₹604 Cr) [CARE26], whereas [SCR] shows ₹687 Cr and a filings aggregator shows ₹681 Cr; the difference likely reflects classification (e.g., treatment of interest/dividend receipts or standalone vs. consolidated). FY26 capex of ~₹263–265 Cr was largely directed at the bromine and vacuum salt projects and was funded from internal accruals. [Q4FY26 call] Historical buybacks before FY26 and dividends paid before FY26: n/d in sources reviewed.

Ratios

ROE and ROA derived on average balances from [SCR]; ROCE, working-capital days and CCC from [SCR]. Debt/equity derived; CARE reports gross gearing of 0.03x (FY25) and 0.02x (FY26), and interest coverage (PBILDT/interest) of 54.87x (FY25) and 70.82x (FY26). [CARE26] CARE separately computes the operating cycle at 96 days in FY26 vs. 107 days in FY25 on its own methodology. ROIC: n/d (ROCE used as proxy). Current ratio: n/d. Note: Screener's high inventory days are computed on its expense base and should be read directionally.

Recent quarterly trajectory (standalone, ₹ Cr)

Sources: revenue [Fyers quarterly data]; EBITDA margins Q4 FY25–Q4 FY26 [ScanX summary of Q4 FY26 results]; Q1 FY27 margin derived from company-reported EBITDA ₹233 Cr on net revenue ₹798 Cr [Q1FY27-PR]; PAT [Torus Digital standalone; Q1FY27-PR]. Q1 FY27 PAT includes an exceptional gain of ₹53.62 Cr; profit before exceptional items and tax was ₹203.91 Cr and tax ₹66.35 Cr. [Investywise summary of Q1 FY27 filing] The exceptional item likely relates to the ESOS Trust broker-litigation settlement (April 2026) — nature not confirmed in sources reviewed.

Commentary on trends, inflections and drivers

Revenue. The FY22–FY23 surge (consolidated revenue +52% then +20%) reflected a global soda ash super-cycle triggered by post-pandemic glass/solar demand, Chinese energy curbs and European energy shocks; FY23 also still contained textiles. FY24's 24% decline combines the demerger with the normalisation of global prices as Chinese natural soda ash capacity (notably in Inner Mongolia) came on stream. FY25 and FY26 revenues fell a further 7.7% and 3.7% despite volume growth (~3% in FY26) because average realisation dropped ~7% to ₹23,709/t in FY26. [CARE26] Import share in India has nearly doubled from a historical ~15% to ~25–26%, structurally capping domestic prices. [Outlook Business, 2026]

Margins. EBITDA margin peaked at ~33% in FY23, compressed to ~25% in FY24, recovered to ~28% in FY25 on lower coal/lignite costs and operational efficiency (FY25 standalone EBITDA rose 7% to ₹966 Cr despite revenue down 6% [Indian Chemical News, May 2025]), then compressed to ~22.5% in FY26 on lower realisations and elevated freight costs linked to West Asia disruption. [CARE26] The quarterly trajectory shows the trough in Q3 FY26 (22.7%) and a sharp rebound to ~29% in Q1 FY27 on "better realisation and lower input costs", although management warned that the global conflict will feed into energy and raw material costs and moderate margins as FY27 progresses. [Q1FY27-PR] Management has also noted that while soda ash prices fell 19% in one year, its margin fell only 5%, evidencing a cost-curve advantage. [Outlook Business]

Below the line. Interest cost collapsed from ₹64 Cr (FY22) to ₹9 Cr (FY26) as gross debt fell from ₹788 Cr to ₹83 Cr. Other income spiked to ₹270 Cr in FY24 (likely including one-off gains around the demerger/treasury; composition n/d) before normalising to ₹73–88 Cr. The FY26 effective tax rate (26%) is close to the statutory new-regime rate.

Balance sheet and cash. The balance sheet has de-levered completely; investments rose from ₹17 Cr to ₹1,042 Cr, and CWIP rose to ₹450 Cr as diversification capex accumulated. Cash conversion is strong (CFO/EBITDA ≥86% every year; 124% in FY26). Capital allocation in FY26 was explicitly shareholder-friendly: ₹415 Cr returned (buyback + dividend) against ₹265 Cr of growth/maintenance capex, while cash and liquid investments still rose to ~₹1,113 Cr.

Returns. ROE has fallen from 32% (FY23) to 13% (FY26), a function of both lower earnings and a cash-heavy equity base; the buyback was explicitly intended to "enhance the return on equity". [BUYBACK]

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

Metric (INR Cr)FY22FY23FY24FY25FY26

Revenue from operations

3,7784,5453,4473,1833,064

Total operating expenses

2,7973,0482,5962,3062,375

EBITDA (operating profit excl. other income)

9821,497851877689

Other income

581242708873

Depreciation

11794102112111

Interest

643927179

Profit before tax

8591,489991836642

Effective tax rate (%)

2523202526

Net profit

6471,142794624472

EPS basic (INR)

67.79119.4182.9465.1851.39

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY22FY23FY24FY25FY26

EBITDA margin (%)

26.032.924.727.622.5

EBIT margin (%)

22.930.921.724.018.9

PBT margin (%)

22.732.828.726.321.0

Net margin (%)

17.125.123.019.615.4

Revenue growth YoY (%)

51.720.3-24.2-7.7-3.7

Net profit growth YoY (%)

98.576.5-30.5-21.4-24.4

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY22FY23FY24FY25FY26

Dividend per share (INR)

—17.5121212

Dividend payout ratio (%)

015141823

Balance Sheet

Metric (INR Cr)FY22FY23FY24FY25FY26

Total assets

4,9955,1333,7704,1854,300

Net fixed assets

2,4741,7311,8421,8441,821

Capital work-in-progress

21310955256450

Investments

173804206511,042

Other assets (incl. inventory, receivables, cash)

2,2922,9141,4531,435987

Equity share capital

9596969692

Reserves

2,9903,8602,8833,3933,460

Total equity

3,0853,9562,9793,4893,552

Total borrowings

78836121011983

Other liabilities

1,122816581578665

Cash and liquid investments

——8921,0731,113

Net debt (negative = net cash)

——-682-954-1,030

Cash Flow and Margin Analysis (%)

Metric (INR Cr)FY22FY23FY24FY25FY26

Cash flow from operations

643856797638687

Cash flow from investing

-337-403-534-358-291

Cash flow from financing

-98-536-338-230-451

Capex (derived: CFO – FCF)

337350106302263

Free cash flow

306506691336424

CFO / EBITDA (%)

868711698124

Buyback (INR Cr)

0—00300

Dividends paid (INR Cr)

————115

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY22FY23FY24FY25FY26

ROE (%)

23.232.422.919.313.4

ROA (%)

14.422.617.815.711.1

ROCE (%)

2535212418

Debt / equity (x)

0.260.090.070.030.02

Net debt / EBITDA (x)

——-0.80-1.09-1.49

EBITDA / interest (x)

15.338.431.551.676.6

Asset turnover (x)

0.840.900.770.800.72

Debtor days

2218192421

Inventory days

204177185217199

Payable days

7453555794

Cash conversion cycle (days)

152142149183126

Margin Analysis (%) (Quarterly)

MetricQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Revenue from operations

781796721757791774

EBITDA margin (company-reported, %)

30.227.323.722.723.929.2

Net profit

152.62144.78107.36106.70119.97191.18

Valuation Snapshot

MetricValueSource

Current price

₹463 (early Oct 2026)

[SCR]

1-year return

–26%

[SCR]

3-year price CAGR

–2%

[SCR]

5-year price CAGR

+13%

[SCR]

10-year price CAGR

+12%

[SCR]

52-week range

₹419 – ₹668

[SCR]

Buyback price (Nov 2025)

₹725 (stock now ~36% below)

[BUYBACK]

Reference points

₹712.85 (1 Jan 2025); ₹519.05 (5 May 2026); ~₹442 (28 Aug 2026)

Angel One; share.market

Metric

FY22

FY23

EPS (INR)

67.79119.41

Book value per share (₹, derived)

324.7412.1

Valuation Multiples

MultipleGHCLBasis

P/E (trailing)

9.0x

[SCR] reported 9.01

P/B

1.20x

₹463 / ₹386 BVPS [SCR]

Enterprise value

~₹3,227 Cr

Mcap ₹4,257 Cr + debt ₹83 Cr – cash & liquid investments ₹1,113 Cr

EV / EBITDA (FY26)

~4.7x

₹3,227 Cr / ₹689 Cr

EV / Sales (FY26)

~1.05x

₹3,227 Cr / ₹3,064 Cr

Dividend yield

2.59%

[SCR]

Peer reference

Tata Chemicals: loss-making on reported FY26 basis (P/E not meaningful)

Tata Chemicals FY26

Share Price & Returns

DateSizePriceSharesMethodStatus

1 Nov 2025

₹300 Cr (8.73% of standalone paid-up capital + free reserves)

₹725

41,37,931 (~4.31% of equity)

Tender offer, proportionate; 15% small-shareholder reservation

Completed Nov–Dec 2025

Credit Ratings

AgencyInstrumentRatingOutlookDate

CARE Ratings

Long-term / short-term bank facilities (₹825 Cr)

CARE AA- / CARE A1+

Stable

Reaffirmed 10 Aug 2026

CARE Ratings

Long-term term loan (₹54.95 Cr, reduced from ₹85.65 Cr)

CARE AA-

Stable

Reaffirmed 10 Aug 2026

Moody's / S&P / Fitch

—

Not rated

——

Capital Instruments

InstrumentAmount (INR Cr)Maturity

Term loan

54.95

30 Jun 2028

Scheduled term-debt repayments

~30 p.a.

Medium term

Fund-based working capital limits

450 (largely unutilised; >₹450 Cr unutilised at 30 Jun 2026)

Annual renewal

Analyst Conclusions

Management guidance (latest)

  • Long-term fundamentals positive; domestic demand to grow 5–6% p.a. with solar glass a key new vector. [Q1FY27-PR]

  • Q1 FY27 margin improvement driven by realisation and lower input costs, but margins expected to moderate as FY27 progresses due to conflict-driven energy and raw material costs. [Q1FY27-PR]

  • Bromine and vacuum salt to start commercial operations in Q2 FY27; ~₹120 Cr revenue at 40–45% EBITDA margin in FY27. [Q1FY27-PR; Q4FY26 call summary]

  • Greenfield soda ash making "slow progress"; no clear timeline due to land acquisition; commissioning by 2030 at the earliest. [Q1FY27-PR; Q1 FY27 call summary]

Consensus expectations

Sell-side consensus: n/d. Independent reference point — CARE's base case of TOI growth of ~4–5% CAGR and PBILDT of ~₹750–850 Cr p.a. in the medium term. [CARE26] For context, FY26 PBILDT was ₹693 Cr, so CARE implies a 8–23% EBITDA recovery from the FY26 base.

Bull case

  1. Import-parity reflation: INR weakness and elevated freight lift landed import prices; with rupee-denominated fixed costs and ~96% utilisation, GHCL's operating leverage is high — Q1 FY27 already showed EBITDA margin recovering to ~29% from 22.7% two quarters earlier.

  2. Trade-remedy catalyst: Implementation of DGTR's recommended US$79–113/t anti-dumping duties, or a successful China-focused petition, would directly reprice the domestic market at a time when imports hold a 25–26% share.

  3. Cheap, cash-rich optionality: At ~4.7x EV/EBITDA and ~1.2x book, with ~₹1,030 Cr net cash (~24% of market cap), investors pay little for the greenfield, the bromine/vacuum salt ramp or future capital returns.

Bear case

  1. Structural price ceiling: Chinese natural soda ash capacity and redirected exports may keep global prices depressed for years; Tata Chemicals' FY26 US goodwill impairment of ₹1,837 Cr signals how deep the trough is.

  2. Growth vacuum: With the plant at 96% utilisation and the greenfield slipping toward 2030+, volume growth is negligible; new businesses (₹120 Cr revenue) are under 4% of revenue.

  3. Capital allocation risk: A ₹4,000–5,000 Cr project (some reports say ₹6,500 Cr) is larger than the entire current market capitalisation; cost overruns, land delays or a poorly timed commissioning into a global glut could dilute returns and introduce ₹2,000–2,500 Cr of debt.

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Late Oct / early Nov 2026Q2 FY27 results — confirmation of bromine and vacuum salt COD; margin trajectory vs. guided moderation
FY27Finance Ministry decision on soda ash anti-dumping duties; MIP renewal/expiry
FY27Greenfield: land acquisition completion, financial closure, EPC award, "zero date" announcement
FY27Any further appeal against NGT ruling
OngoingLanded import price (China/Turkey FOB + freight + INR); domestic realisation per tonne vs. FY26's ₹23,709/t
OngoingCoal, coke, lignite, salt and freight costs (West Asia)
Q3 FY28 (beyond window, but priced in early)Tata Chemicals' 350 kt Mithapur dense ash commissioning
OngoingCapital allocation — further buybacks vs. cash conservation for greenfield
Aug 2027Next CARE rating review

Analyst verdict

GHCL today is a well-run, cash-generative commodity franchise trading at a valuation that already discounts a prolonged downcycle. The core facts are unambiguous: the Sutrapada plant runs at roughly 96% utilisation, the company holds about ₹1,113 crore of cash and liquid investments against ₹83 crore of debt, operating cash flow consistently exceeds most of EBITDA, and management returned ₹415 crore to shareholders in FY26 while still funding diversification capex internally. Its cost discipline — a 19% fall in soda ash prices translating into only a 5% margin hit — is the hallmark of a low-cost synthetic producer.

Against that, the earnings line has deteriorated for three straight years, from ₹1,142 crore of profit in FY23 to ₹472 crore in FY26, because GHCL is a price-taker in a market where imports now hold a quarter of share and the government's protective tools have been slow and leaky. The near-term P&L hinges on variables management does not control — Chinese export pricing, freight, the rupee and trade-remedy decisions. The long-term equity story hinges on the Kutch greenfield, whose timeline has slipped repeatedly despite the August 2026 NGT win and whose cost is now larger than the company's market value.

On balance, the risk-reward is asymmetric in investors' favour at ~4.7x EV/EBITDA, ~1.2x book and a ~2.6% dividend yield, provided capital allocation remains disciplined. The base case is modest EBITDA recovery toward CARE's ₹750–850 crore range as bromine and vacuum salt ramp up and import parity firms; upside comes from anti-dumping duties or a sustained freight-driven price reset; downside is bounded by the net-cash balance sheet but would materialise through a debt-funded greenfield commissioned into a global glut. The stock is best viewed as a value-with-catalysts holding, with Q2 FY27 commissioning confirmation and greenfield financial closure as the critical proof points to monitor.


APPENDIX A — DATA DISCREPANCIES NOTED

ItemSource ASource BTreatment
Greenfield capacity5 lakh MTPA (2023 announcement)5.5 lakh MTPA Phase I; 11 lakh MTPA total in two phases ([BSE-2024]; [CARE26])Used CARE/BSE (latest primary)
Greenfield cost₹4,000 Cr Phase I + ~₹1,000 Cr Phase II [CARE26]₹6,500 Cr for 1.1 MTPA (media, Oct 2025)Both reported; CARE preferred
FY26 operating cash flow₹719 Cr [CARE26]₹687 Cr [SCR]; ₹681 Cr (filings aggregator)Screener used in tables; discrepancy flagged
Revenue definitionCompany "net revenue" includes other income (e.g., FY25 ₹3,273 Cr)Revenue from operations (FY25 ₹3,183 Cr consolidated)Revenue from operations used in tables
Incorporation date14 Oct 1983 (MCA/BRSR)21 Jul 1983 (EMIS)MCA/BRSR used
Employees497 permanent employees (BRSR FY24)3,439 (PitchBook); 1,037 (EMIS 2026); ~1,298 (registry)BRSR used
HeadquartersRegistered office AhmedabadSeveral databases cite Noida (corporate office)Both disclosed
Q1 FY26 standalone PAT₹144.78 Cr (Torus standalone series)₹144.11 Cr (cited as standalone in one news item; matches consolidated series)₹144.78 Cr used for standalone

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NamePositionCategoryTenure / key datesBackgroundSource

Anurag Dalmia

Non-Executive Chairman

Promoter, Non-Executive

Chairman since 30 Jun 2023; committee member since 29 Jul 2021; also Chairman of GHCL Textiles since 6 May 2024

Shri Ram College of Commerce; Director, Dalmia Foundation, Bharat Explosives Ltd; former Vice Chairman, Golden Tobacco (2011–14); holds ~1.25 lakh GHCL shares (0.14%)

MarketScreener; [NSE-GOV]

R S (Ravi Shanker) Jalan

Managing Director

Executive

Long-serving MD (management average tenure ~13.7 years per Simply Wall St)

Chartered accountant by background (†); public face of the company on industry policy (MIP/ADD)

[CARE25]; company releases

Raman Chopra

CFO & Executive Director (Finance)

Executive

Long-serving; also described by CARE as linked to GHCL Textiles management

Finance leadership; leads earnings calls with MD

[Q1FY27 call]; [CARE25]

Neelabh Dalmia

Executive Director (Whole-Time Director)

Promoter, Executive

On board since 2005 (committee data show 20-Jul-2005); reappointed WTD Oct 2024

Born 16 Aug 1983 (age 43); son of Anurag Dalmia

NSE filing 29 Oct 2024

Vijaylaxmi Joshi

Independent Director

Independent, Non-Executive

—

Retired senior civil servant (†)

Choice India

Dr. Manoj Vaish

Independent Director

Independent, Non-Executive

—

Former financial-services executive (†)

Choice India

Arun Kumar Jain

Independent Director

Independent, Non-Executive

——

Choice India; [NSE-GOV]

Justice Ravindra Singh (Retd.)

Independent Director (status at GHCL to be confirmed)

Independent

Tenure on GHCL Textiles board ended 31 Mar 2026

Retired High Court judge

[NSE-GOV]

Executive Leadership Team

NameRoleSource

Bhuwneshwar Mishra

VP – Sustainability & Company Secretary

[BSE-2024]

Shalabh Agarwal

Senior management (role n/d)

Simply Wall St

Board & Management Changes

DateChangeContext

30 Jun 2023

Anurag Dalmia becomes Non-Executive Chairman

Generational transition within promoter family (†: succeeding Sanjay Dalmia)

29 Oct 2024

Neelabh Dalmia reappointed WTD/ED

Continuity of promoter executive presence

1 Apr 2026

Justice Ravindra Singh ceases as director of GHCL Textiles (tenure completed)

Sister-company governance change

Shareholding Trend

Holder category (%)Mar 2025Jun 2025Sep 2025Dec 2025Jun 2026

Promoters & promoter group

19.0418.9818.9819.8319.81

Foreign institutional investors

26.0726.4125.6725.2222.40

Mutual funds

8.808.818.977.90—

Other domestic institutions

1.311.481.561.601.70

Retail and others

44.7944.3344.8245.4546.50

Major Shareholders

RankHolderValue held (INR Cr)Implied stake (%, derived on ₹4,040 Cr mcap)
1

DSP Small Cap Fund

103.242.6
2

Franklin India Small Cap Fund

72.551.8
3

DSP ELSS Tax Saver Fund

57.461.4
4

UTI Large & Mid Cap Fund

55.571.4
5

UTI Aggressive Hybrid Fund

47.511.2
6

UTI Retirement Fund

19.140.5
7

ICICI Prudential Smallcap Fund

17.260.4
8

HDFC Dividend Yield Fund

16.800.4
9

Motilal Oswal Nifty Microcap 250 Index Fund

9.260.2
10

Groww Nifty Total Market Index Fund

0.060.0

Competitive Landscape

Key Competitors

CompetitorType / listingSoda ash positionComparative scale (latest available)Relative positioning vs GHCLSource

Tata Chemicals Ltd

Listed (NSE: TATACHEM)

Largest Indian producer (Mithapur, Gujarat); produced 1 MTPA in FY26; dense soda ash expansion of 350 kt at Mithapur targeted Q3 FY28; global operations in US (natural), UK, Kenya

FY26 consolidated revenue ₹14,584 Cr (–2%); consolidated net loss ₹1,715 Cr after ₹1,956 Cr exceptional charges

Larger, diversified (incl. Rallis agrochemicals); India business stronger than overseas; capacity addition is a competitive threat

Tata Chemicals FY26 release; Q4 FY26 deck

Nirma Ltd

Private

Major producer (Bhavnagar/Porbandar, Gujarat; also captive detergent consumption)

n/d (private)

Integrated detergent user; price setter in light ash

—

DCW Ltd

Listed

Soda ash producer (Dhrangadhra, Gujarat †); co-petitioner with GHCL in trade remedies

—

Smaller, more diversified (caustic, PVC)

Chemexcil

RSPL Ltd (Ghari)

Private

Soda ash producer (Kutch †); integrated with Ghari detergents

—

Integrated detergent player

Chemexcil

Chinese producers (e.g., Inner Mongolia natural soda ash plants; Shandong Haihua)

Listed/private, China

China is the world's largest producer; large new natural ash capacity driving global surplus

—

Primary source of import pressure

Outlook Business

Turkish producers (ETI Soda, Kazan Soda Elektrik — WE Soda group)

Private/listed (UK-listed WE Soda plans)

Low-cost natural soda ash exporters

—

Target of DGTR findings (Jan 2021)

DGTR via Chemexcil

US natural soda ash exporters (Genesis Alkali, Ciner/Sisecam Wyoming, Tata Chemicals North America)

Various

Natural trona-based, low cost

—

Export pressure into Asia

DGTR; Tata Chemicals

Russian producers (e.g., Bashkir Soda)

Private

Exporter subject to DGTR findings

—

Import competition

ScanX (DGTR findings)

Iranian producers

Various

Exporter subject to DGTR findings

—

Import competition

ScanX (DGTR findings)

Solvay (Belgium)

Listed

Global synthetic soda ash leader

—

Limited direct India presence

—

Peer Comparison FY2026

MetricGHCLTata Chemicals (consolidated)

Revenue (INR Cr)

3,06414,584

Revenue growth YoY (%)

–3.7

–2.0

EBITDA margin (%)

22.5

Low double digits (Q4 FY26 EBITDA ₹274 Cr on ₹3,438 Cr ≈ 8%)

Net margin (%)

15.4

Negative (net loss ₹1,715 Cr)

India soda ash capacity / output

1.2 MTPA capacity, ~96% utilisation

~1.0 MT production at Mithapur in FY26

Net debt

Net cash ~₹1,030 Cr

—

Company Snapshot

$353.8M

Revenue

744

Employees

1983

Founded

Gujarat, India

Headquarters

SWOT Analysis

Strengths

  • Market leadership: India's #2 soda ash producer with ~26% domestic share in an oligopoly where the top four control ~85% of capacity. [CARE26]
  • Operational excellence: ~96% capacity utilisation in FY26 (FY25: ~95%) on a 12 lakh MTPA plant. [CARE26]
  • Fortress balance sheet: Gross debt ₹83 Cr vs. cash and liquid investments ~₹1,113 Cr (FY26); gearing 0.02x; interest coverage 70.8x. [CARE26]
  • Cash generation: CFO exceeded 86% of EBITDA in each of FY22–FY26 (124% in FY26). [SCR]
  • Cost resilience: In a year when soda ash prices fell 19%, GHCL's margin fell only 5%. [Outlook Business, MD interview]
  • Partial backward integration: Captive salt (3 lakh MTPA), limestone and lignite sources, plus a 30-year 6,449-ha salt lease at Zara Zumara. [CARE26; Q1 FY25 call]
  • Shareholder returns: ₹415 Cr returned in FY26 (₹300 Cr buyback at a ~20% premium + ₹115 Cr dividends). [Q4FY26; BUYBACK]

Weaknesses

  • Earnings decline: Consolidated PAT has fallen for three consecutive years — ₹1,142 Cr (FY23) → ₹794 Cr → ₹624 Cr → ₹472 Cr (FY26). [SCR]
  • Concentration: ~98.3% of standalone revenue from one product at one site. [SCR]
  • Price-taker economics: Domestic prices track landed import prices absent duties/quotas; FY26 realisation fell 7% to ₹23,709/t. [CARE26]
  • Synthetic process disadvantage: No access to natural trona; competing exporters have structurally lower costs. [Outlook Business]
  • Volume ceiling: Plant at near-peak utilisation with "limited scope for material brownfield expansion" — growth depends on a multi-year greenfield. [CARE26]
  • Low promoter holding / governance overlap: Promoters hold only ~19.8%; common management with GHCL Textiles is flagged by CARE as a monitorable. [CARE26; CARE25]
  • Declining ROE: 32% (FY23) → 13% (FY26), weighed down by cash drag. [SCR; derived]

Opportunities

  • Demand growth: Indian demand expected to grow 6–7% p.a. through 2031, adding 2.5–3.0 lakh tonnes per year. [CARE26; Q1FY27-PR]
  • Solar glass: Expected to consume ~8–9% of Indian soda ash soon, supported by ADD and PLI for solar glass. [Q1 FY27 call summary; Outlook Business]
  • Greenfield doubling: 11 lakh MTPA Kutch project could lift capacity to ~23 lakh MTPA by ~2030; NGT clearance appeals dismissed (Aug 2026). [CARE26; Sahi]
  • High-margin diversification: Bromine/vacuum salt targeted at ~₹120 Cr revenue at 40–45% EBITDA margin in FY27; Bromine Phase 2 of 10–12 kt planned. [Q4FY26 call summary]
  • Trade remedies: Pending/possible anti-dumping duties (DGTR recommended US$79–113/t on four countries; fresh petitions against China in 2026). [ScanX; Outlook Business]
  • Import-parity tailwind: INR depreciation and higher freight raise landed import prices, which CARE says would lead to sizable profit growth given GHCL's cost structure. [CARE26]

Threats

  • Chinese overcapacity: Import share has nearly doubled to 25–26%. [Outlook Business]
  • Competitor expansion: Tata Chemicals' 350 kt dense soda ash expansion at Mithapur (target Q3 FY28). [Tata Chemicals Q4 FY26 deck]
  • Greenfield execution risk: Land acquisition delays, no clear timeline, financial closure awaited, ₹4,000–5,000 Cr cost (or ₹6,500 Cr per some reports). [CARE26; Q1 FY27 call summary]
  • Geopolitical input-cost shocks: West Asia conflict raising freight and energy costs; management expects margins to moderate through FY27. [Q1FY27-PR]
  • Policy reversal risk: MIP is time-bound and has been leaky; ADD history shows duties can be revoked (2017). [Delhi HC; MoF 2017]
  • Currency: Net importer of inputs (e.g., limestone, coke); hedges only ~3 months of payables. [CARE26]

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
12 May 2025Q4 FY25 results: standalone net revenue ₹807 Cr (–4% YoY), EBITDA ₹244 Cr (+22%), PAT ₹153 Cr (+23%); FY25 net revenue ₹3,273 Cr (–6%), EBITDA ₹966 Cr (+7%) Indian Chemical NewsDemonstrated cost-led margin expansion despite falling prices
30 Jun 2025MIP on soda ash extended by DGFT Notification 23/2025-26 beyond its initial 30 Jun 2025 sunset Delhi HC order (9 Oct 2025)Policy floor maintained
Jul 2025Lease renewal approval from Gujarat Industries & Mines Department (captive mineral lease) Jhaveri Trade news feedSecures captive raw material
31 Jul / 7 Aug 2025CARE reaffirms AA-; Stable / A1+; withdraws rating on repaid term loans [CARE25]Credit strength confirmed
Aug 2025Q1 FY26 results: net revenue ₹823 Cr, standalone PAT ~₹145 Cr ICN; Q1 FY27 comparativesStart of margin compression (27.3%)
Late Sep 2025Planned maintenance shutdown at Sutrapada ScanXHit Q2 FY26 volumes
9 Oct 2025Delhi High Court disposes AMAI writ directing authorities to enforce the MIP policy in letter and spirit Delhi HC W.P.(C) 11521/2025Addresses sub-MIP leakage
Oct 2025Reports that Kutch land secured and environmental clearance obtained; construction expected to begin in 6–7 months; project framed as ₹6,500 Cr for 1.1 MTPA Angel One (17 Oct 2025)Raised expectations on greenfield timing (later delayed)
1 Nov 2025Q2 FY26 results: revenue from operations ₹721 Cr (–9% YoY), standalone PBT ₹145 Cr; board approves ₹300 Cr buyback at ₹725 [BUYBACK]; ScanXCapital return amid soft earnings; awaiting Finance Ministry decision on DGTR ADD recommendation
14 Nov 2025Buyback record date [BUYBACK]—
20–26 Nov 2025Buyback tender window; 15% reserved for small shareholders; promoters abstain [BUYBACK]~4.3% of equity retired
29 Jan 2026Q3 FY26 results: EBITDA margin 22.7% (–100 bps QoQ on lower realisation) [Q3FY26]Margin trough
7 Mar 2026Board meeting (agenda n/d) [NSE-GOV]—
Q4 FY26First line of bromine/vacuum salt diversification commissioned [Q4FY26] callDiversification milestone
14 Apr 2026ESOS Trust settles broker litigations; to receive 7,45,966 GHCL shares and 8,56,466 GTL shares [SCR]Resolution of legacy dispute
Apr–May 2026MD R S Jalan publicly seeks anti-dumping duty on imports from China and others; DGTR examining petitions; import share 25–26% vs 15% historically Outlook Business; India Sea Trade NewsTrade-remedy catalyst
5 May 2026Q4 FY26 results: standalone PAT ₹119.97 Cr (–21% YoY, +12% QoQ); FY26 standalone PAT ₹478.81 Cr (–24%); consolidated FY26 PAT ₹472 Cr; ₹12 dividend recommended; 26% domestic market share ScanX; Angel OneWeak year, sequential recovery
5 May 2026Board approves budgets and auditor appointments (incl. internal auditors for Soda Ash and Consumer Products divisions) ScanXGovernance routine
7 May 2026FY26 annual secretarial compliance report filed — no non-compliances [SCR]Clean compliance record
Jun 2026Allotment of 1.96 lakh equity shares under ESOP Torus DigitalMinor dilution
18 Jun 2026Record date for ₹12 dividend ScanX—
25 Jun 202643rd AGM ScanX; Angel OneDividend approved (payable on/after 25 Jun 2026)
31 Jul / 10 Aug 2026CARE reaffirms AA-; Stable / A1+; flags weaker-than-envisaged FY26 and greenfield execution risk [CARE26]Rating stable despite earnings miss vs CARE's expectations
1 Aug 2026Q1 FY27 results: standalone revenue from operations ₹774 Cr; PAT ₹191 Cr (+32% YoY) incl. ₹53.6 Cr exceptional gain; EBITDA ₹233 Cr (+4%) [Q1FY27-PR]Margin rebound to ~29%
3 Aug 2026Q1 FY27 earnings call: net cash >₹1,000 Cr; greenfield delayed by land acquisition with no clear timeline; solar glass to take 8–9% of demand Arthneeti; InvestywiseGreenfield timeline risk
21 Aug 2026NGT Western Zone Bench dismisses all three appeals against Kutch project environmental and forest clearances SahiRemoves key legal overhang
Q2 FY27 (Jul–Sep 2026)Scheduled commercial operations of bromine and vacuum salt plants [Q1FY27-PR]Confirmation pending in Q2 FY27 results (expected late Oct/early Nov 2026)

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

1 chart
Income Statement: Total operating expenses fell from INR 27,970 Mn in FY2022 to INR 23,750 Mn in FY2026.
GHCL Limited — Income Statement
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Total operating expenses27,97030,48025,96023,06023,750
Revenue from operations37,78045,45034,47031,83030,640
EBITDA (operating profit excl. other income)9,82014,9708,5108,7706,890
Other income5801,2402,700880730
Depreciation1,1709401,0201,1201,110
Interest64039027017090
Profit before tax8,59014,8909,9108,3606,420
Net profit6,47011,4207,9406,2404,720

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Screener.in — GHCL consolidated financials FY15–FY26, ratios, announcements (accessed Oct 2026).
  2. CARE Ratings — Press releases on GHCL Limited dated July 2023, 7 Aug 2025 and 10 Aug 2026; GHCL Textiles releases July 2025, Jan 2026, July 2026.
  3. GHCL — Q1 FY27 investor presentation and press release (NSE, 1 Aug 2026); Q4 FY26 results and earnings call (5 May 2026); Q3 FY26 call transcript (29 Jan 2026); buyback resolution (NSE, 3 Nov 2025); board corrigendum (BSE, 7 May 2024); Neelabh Dalmia appointment (NSE, 29 Oct 2024); Q4 FY26 integrated governance filing (NSE, Apr 2026); promoter declaration (NSE, Apr 2026); BRSR FY22 and FY24; Integrated Annual Report FY22; 2023 press release on soda ash demand.
  4. Indian Chemical News — Q4 FY25 (May 2025), Q4 FY26 (May 2026), Q1 FY27 (Aug 2026) coverage; 2023 greenfield announcement.
  5. Outlook Business / Chemindigest / India Sea Trade News — MD interview on anti-dumping duties and import share (2026).
  6. DGFT Notification 46/2024-25 (30 Dec 2024) via Taxscan/Taxguru; Delhi High Court W.P.(C) 11521/2025 order (9 Oct 2025); DGTR final findings (Jan 2021) via Chemexcil; Ministry of Finance notifications 08/2013 and 51/2017.
  7. ScanX, FilingReader, Investywise, Sahi, Arthneeti, Angel One, Upstox, Geojit, share.market, Choice India, Equitymaster, Torus Digital, Fyers, Kotak Neo, Jhaveri Trade — secondary summaries of exchange filings, shareholding and market data.
  8. MarketScreener (Anurag Dalmia profile); PitchBook and EMIS (company profiles); Simply Wall St (management tenure).
  9. Tata Chemicals — FY26 and Q1 FY27 press releases and Q4 FY26 investor deck (peer data).

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.